These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9124093)

  • 1. [Potential of photodynamic therapy with a second-generation sensitizer: mono-L-aspartyl chlorin e6].
    Mori K; Ohta M; Sano A; Yoneya S; Sonoda M; Kaneda A; Sato Y
    Nippon Ganka Gakkai Zasshi; 1997 Feb; 101(2):134-40. PubMed ID: 9124093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6).
    Mori K; Yoneya S; Ohta M; Sano A; Anzai K; Peyman GA; Moshfeghi DM
    Ophthalmology; 1999 Jul; 106(7):1384-91. PubMed ID: 10406627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: mono-L-aspartyl chlorin e6.
    Mori K; Yoneya S; Anzail K; Kabasawa S; Sodeyama T; Peyman GA; Moshfeghi DM
    Retina; 2001; 21(5):499-508. PubMed ID: 11642380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Threshold power levels for NPe6 photodynamic therapy.
    Kazi AA; Peyman GA; Unal M; Khoobehi B; Yoneya S; Mori K; Moshfeghi D; Moshfeghi AA
    Ophthalmic Surg Lasers; 2000; 31(2):136-42. PubMed ID: 10743925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy of intestinal tumors with mono-L-aspartyl chlorin e6 (NPe6): a basic study.
    Kikuchi T; Asakura T; Aihara H; Shiraki M; Takagi S; Kinouchi Y; Aizawa K; Shimosegawa T
    Anticancer Res; 2003; 23(6C):4897-900. PubMed ID: 14981942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endovascular photodynamic therapy using mono-L-aspartyl-chlorin e6 to inhibit Intimal hyperplasia in balloon-injured rabbit arteries.
    Nagae T; Aizawa K; Uchimura N; Tani D; Abe M; Fujishima K; Wilson SE; Ishimaru S
    Lasers Surg Med; 2001; 28(4):381-8. PubMed ID: 11344521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Threshold and retreatment parameters of NPe6 photodynamic therapy in retinal and choroidal vessels.
    Peyman GA; Kazi AA; Moshfeghi D; Unal M; Khoobehi B; Yoneya S; Mori K; Rivera I
    Ophthalmic Surg Lasers; 2000; 31(4):323-7. PubMed ID: 10928670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photosensitizing properties of mono-L-aspartyl chlorin e6 (NPe6): a candidate sensitizer for the photodynamic therapy of tumors.
    Spikes JD; Bommer JC
    J Photochem Photobiol B; 1993 Feb; 17(2):135-43. PubMed ID: 8459317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy with mono-L-aspartyl chlorin e6 can cause necrosis of squamous cell carcinoma of tongue: experimental study on an animal model of nude mouse.
    Kobayashi W; Liu Q; Nakagawa H; Sakaki H; Teh B; Matsumiya T; Yoshida H; Imaizumi T; Satoh K; Kimura H
    Oral Oncol; 2006 Jan; 42(1):46-50. PubMed ID: 16266818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model.
    Wong Kee Song LM; Wang KK; Zinsmeister AR
    Cancer; 1998 Jan; 82(2):421-7. PubMed ID: 9445202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retreatment effect of NPe6 photodynamic therapy on the normal primate macula.
    Nakashizuka T; Mori K; Hayashi N; Anzail K; Kanail K; Yoneya S; Moshfeghi DM; Peyman GA
    Retina; 2001; 21(5):493-8. PubMed ID: 11642379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study.
    Taber SW; Fingar VH; Coots CT; Wieman TJ
    Clin Cancer Res; 1998 Nov; 4(11):2741-6. PubMed ID: 9829737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces.
    Chan AL; Juarez M; Allen R; Volz W; Albertson T
    Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):72-8. PubMed ID: 15752124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy using mono-L-aspartyl chlorin e6 for rabbit experimental hepatoma.
    Nakamura J; Kajiwara H
    J Hepatobiliary Pancreat Surg; 1999; 6(3):312-9. PubMed ID: 10526068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of vascular endothelial growth factor by photodynamic therapy with mono-L-aspartyl chlorin e6 (NPe6) in oral squamous cell carcinoma.
    Nakagawa H; Matsumiya T; Sakaki H; Imaizumi T; Kubota K; Kusumi A; Kobayashi W; Kimura H
    Oral Oncol; 2007 Jul; 43(6):544-50. PubMed ID: 17257889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of photodynamic therapy using a fractionated dosing of mono-L-aspartyl chlorin e6 in a murine tumor.
    Webber J; Leeson B; Fromm D; Kessel D
    J Photochem Photobiol B; 2005 Feb; 78(2):135-40. PubMed ID: 15664500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung.
    Kato H; Furukawa K; Sato M; Okunaka T; Kusunoki Y; Kawahara M; Fukuoka M; Miyazawa T; Yana T; Matsui K; Shiraishi T; Horinouchi H
    Lung Cancer; 2003 Oct; 42(1):103-11. PubMed ID: 14512194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic evaluation of the antitumor activity of photodynamic therapy (PDT) using mono-L-aspartyl chlorin e6 (NPe6) against uterine cervical carcinoma cell lines.
    Nakamura H; Suzuki Y; Takeichi M; Saito T; Takayama M; Aizawa K
    Int J Gynecol Cancer; 2002; 12(2):177-86. PubMed ID: 11975677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence properties of a hydrophilic sensitizer in pigmented rats, rabbits, and monkeys.
    Moshfeghi D; Peyman GA; Kazi AA; Unal M; Khoobehi B; Yoneya S; Mori K
    Ophthalmic Surg Lasers; 1999; 30(9):750-3. PubMed ID: 10574497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy with a diode laser for implanted fibrosarcoma in mice employing mono-L-aspartyl chlorin E6.
    Katsumi TA; Aizawa K; Kuroiwa Y; Saito K; Kurata Y; Ii Y; Okunaka T; Konaka C; Kato H
    Photochem Photobiol; 1996 Oct; 64(4):671-5. PubMed ID: 8863472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.